Hillary Harel
CEO
Innovative decision support tools for health service industry increasing quality of care and saving valuable resources.
Read more...
-
AI-based objective personalized decision-making.
-
Comprehensive review of all relevant factors and its impact.
-
Alternative conservative recommendations.
-
Improved patient history and data flow.
-
Advanced dashboard and powerful AI-driven analytics
Watch video
Dan Berachowitz
CTO
Prof. Joesf Elidan
CMO
Highlights
Top clinical and AI/ML Experts
Multiple signed paid pilots and growing pipeline of clients and distribution partners
Patent claims have been registered
Awarded and Granted by four government entities including the Bilateral Bird Grant
​
Winner of Department for International Trade (DIT’s) first-ever "2020 European Women in Tech"
​
Named Top AI startup company in "Healthcare Innovation Landscape 2020" Data Roots Labs report
​
1st Place Winner of MTL Tech Awards 2020 by Printemps numérique and Deloitte OVHcloud
Company Overview
Amir Elhasid
VP BD
Prof. David Price
CMO
Gad Riesenfeld
CEO
Low medication adherence, a major cause of poor outcomes and increased costs, is hard to recognize and manage. TimeStamp’s pioneering approach enables the incorporation of IoT into medication providing adherence data into everyday healthcare systems.
Read more...
The docdok platform ​enables optimal patient care at your fingertip, supporting health care professionals within their workflows and ​enabling patients to take better care of their health. We are addressing the global market with a first focus on Germany and chronic respiratory diseases like Asthma & COPD. This solution is co-developed with two of the top 10 hospitals of the world, Sheba and University Hospital Zurich and in partnership with AstraZeneca. As a key to market access in Germany, where a new law obligates payers to reimburse DTx solutions, docdok.health has entered an exclusive partnership with SpiFa, the German umbrella organization of specialized physicians with over 160000 members. The pre-certified building block approach allows for ​the quick development of DTx products for other disease areas, leading to a ​strong pipeline.
Watch video
Highlights
Completed the development of first engineering model and app
3 Patents submitted
Collaboration with a leading pharma company to develop customized solution
Company Overview
Ian Solomon
CTO
Danny Lieberman
CEO
Read more...
The docdok platform ​enables optimal patient care at your fingertip, supporting health care professionals within their workflows and ​enabling patients to take better care of their health. We are addressing the global market with a first focus on Germany and chronic respiratory diseases like Asthma & COPD. This solution is co-developed with two of the top 10 hospitals of the world, Sheba and University Hospital Zurich and in partnership with AstraZeneca. As a key to market access in Germany, where a new law obligates payers to reimburse DTx solutions, docdok.health has entered an exclusive partnership with SpiFa, the German umbrella organization of specialized physicians with over 160000 members. The pre-certified building block approach allows for ​the quick development of DTx products for other disease areas, leading to a ​strong pipeline.
Watch video
Automated patient data collection and monitoring for increasing patiane adirance and clinical clinical reserch efficiancy.
Dr. Dan Peres
CPO
Eugene Kalosha
CTO
Highlights
35 clinical trials on the platform
​
20 customers including Philips, Theranica Therapeutics and Wiseman institute
​
9M patient/device signals
​
3 FDA approvals
​
Cash-flow positive
Company Overview
Dr. Ulrich Mühlner
Co-Founder & CEO
docdok.health is the "Netflix of Healthcare" utilizing the power of patient generated health data to ​provide tailored medical grade application and digital therapeutics (DTx).
Yves Nordmann, M.D.
Co-Founder & CMO
Eitan Arat
CTO
Read more...
The docdok platform ​enables optimal patient care at your fingertip, supporting health care professionals within their workflows and ​enabling patients to take better care of their health. We are addressing the global market with a first focus on Germany and chronic respiratory diseases like Asthma & COPD. This solution is co-developed with two of the top 10 hospitals of the world, Sheba and University Hospital Zurich and in partnership with AstraZeneca. As a key to market access in Germany, where a new law obligates payers to reimburse DTx solutions, docdok.health has entered an exclusive partnership with SpiFa, the German umbrella organization of specialized physicians with over 160000 members. The pre-certified building block approach allows for ​the quick development of DTx products for other disease areas, leading to a ​strong pipeline.
Watch video
Highlights
Internationally multi-awarded digital health company, first European startup selected for ARC partnership
​
Clinical work co-developed with two of the Top 10 Hospitals of the World 2020
​
Multiple top-notch clients and partners like Novartis, AstraZeneca, NovoNordisk, IBM or T-Systems
​
Active in 5 countries (CH, D, AT, IL and Qatar)
Company Overview
Arik Ben Ishay
CEO
Biobeat has developed an AI-based end-to-end solution for remote patient monitoring. The core of the technology lies in Biobeat’s proprietary sensor, which is able to monitor 15 vital signs wirelessly, continuously and non-invasively.
Read more...
Currently there is no effective way to monitor respiratory outpatients.
Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.
Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions
Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.
Watch video
Johanan May
CTO
Israel Sarussi
VP R&D
Highlights
$5M in sales across the US and Europe.
​
Implemented in 13 Hospitals in under 4 weeks for COVID-19 monitoring
​
Multiple signed MSAs with the world’s biggest pharma companies and CROs
​
Several paid pilots and POCs lined up in the US throughout the next year.
Company Overview
Guy Vinograd
CEO
Boaz Vaizler
COO
Daniel Adler
CBO
Bio-T has developed a cloud software that enables medical device manufacturers to seamlessly convert their medical devices to IoT creating a data collection system that manages their device and provides remote care.
Read more...
Currently there is no effective way to monitor respiratory outpatients.
Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.
Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions
Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.
Watch video
Highlights
Completed MVP and launched with initial clients, including $Bn mkt cap companies.
​
Used by thousands of patients in the US market
​
Closely partnered with Amazon AWS
​
Growing pipeline with multiple Top 10 lifescience companies
Company Overview
Aviv Lotan
CEO
Developing the 1st respiratory Holter, a small patch, accurately, continuously and passively monitors respiratory patients at all ages.
Dr. Zvi Reznic
CTO
Dr. Ari Derowe
CMO
Read more...
Currently there is no effective way to monitor respiratory outpatients.
Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.
Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions
Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.
Watch video
Highlights
Successful clinical POC
​
Patent granted in the US
​
Growing interest in clinical collaboration
​
$1M approved funds from the Israeli Innovation Authority (to be matched)
Company Overview
Hila Goldman-Aslan
CEO
Michal Yaacobi
CTO
DiA is the leading provider of AI-powered ultrasound analysis solutions. DiA transforms the way clinicians capture and analyze ultrasound images.
Our vision is to leverage AI to make the use and analysis of ultrasound images smarter and accessible to all.
Read more...
The ultrasound market is rapidly growing, with ultrasound being the only imaging modality (vs. MR/CT/X-Ray) that continues to expand into new clinical settings including ER, ICU, internal medicine, EMS, special forces unit and GPs. Additional key market drivers include ultrasound devices’ portability, decreasing prices and growing improvements of image quality. Yet, capturing and evaluating ultrasound images is still mostly done visually. Such a process is error prone, time consuming and dependent on the user’s experience.
Our FDA/CE approved solutions automate this process, therefore making the use and analysis of ultrasound images smarter and accessible to all.
Watch video
Highlights
7 FDA and CE approved solutions
​
8 Channle Partners including GE Healthcare, IBM Watson Health, and Konica Minolta
​
Serving thousands of end-users in more than 20 countries
Company Overview